Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gevokizumab in non-infectious intermediate, posterior, or pan-uveitis
CTR20150270Phase 3Suspended
- Sponsor
- Servier
- Start
- Jul 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of gevokizumab in uveitis, sponsored by Servier. Started Jul 2015; status: suspended.
02
Drugs
gevokizumab
03
Conditions
uveitis
Beyond the preview
Go deeper on CTR20150270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150270.